www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Cellectis-stem-cells-today-proudly-announces-the-launch-of-the-world-s-very-first-human-iPS-cell-derived-hepatocyte-product-1876713 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: <b>Cellectis stem cells, a Business Unit of</b> <b>Cellectis Group ...http://www.finanzen.net/nachricht/Cellectis-stem-cells-today-proudly-announces-the-launch-of-the-world-s-very-first-human-iPS-cell-derived-hepatocyte-product-1876713http://www.finanzen.net/nachricht/Appointment-of-Mathieu-Simon-MD-to-the-Position-of-Senior-Vice-President-of-Cellectis-Group-1772229 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: <b>Cellectis (Paris: ALCLS), the French specialist in genome engineering ...http://www.finanzen.net/nachricht/Appointment-of-Mathieu-Simon-MD-to-the-Position-of-Senior-Vice-President-of-Cellectis-Group-1772229http://www.finanzen.net/nachricht/Cellectis-announces-the-redemption-of-the-bonds-redeemable-into-shares-subscribed-by-the-FSI-and-Pierre-Bastid-for-a-total-of-50-million-1647826 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: <b>Cellectis (Paris:ALCLS) (Alternext: ALCLS), the French genome engineering ...http://www.finanzen.net/nachricht/Cellectis-announces-the-redemption-of-the-bonds-redeemable-into-shares-subscribed-by-the-FSI-and-Pierre-Bastid-for-a-total-of-50-million-1647826http://www.finanzen.net/nachricht/Cellectis-Plant-Sciences-Announces-the-Signature-of-a-Strategic-Partnership-with-SESVanderHave-in-Sugar-Beet-1604596 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: Cellectis (Paris:ALCLS) plant sciences, the plant genome engineering ...http://www.finanzen.net/nachricht/Cellectis-Plant-Sciences-Announces-the-Signature-of-a-Strategic-Partnership-with-SESVanderHave-in-Sugar-Beet-1604596http://www.finanzen.net/nachricht/Changes-in-the-Group-s-Scientific-Division-and-Appointment-of-the-CEO-of-Cellectis-Plant-Sciences-1603429 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: <b>Cellectis  (Paris:ALCLS)(Alternext: ALCLS), the French genome engineering ...http://www.finanzen.net/nachricht/Changes-in-the-Group-s-Scientific-Division-and-Appointment-of-the-CEO-of-Cellectis-Plant-Sciences-1603429http://www.finanzen.net/nachricht/Medicago-and-Cellectis-Enter-into-Research-Agreement-to-Improve-Therapeutic-Proteins-Using-Nuclease-Technology-1568482 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwalignl {text-align: left} .bwuline {text-decoration: underline} --> </style> <p class="bwalignl"> Regulatory News: <!-- sh_cad_1 --> <b>Medicago Inc. (TSX: MDG), ...http://www.finanzen.net/nachricht/Medicago-and-Cellectis-Enter-into-Research-Agreement-to-Improve-Therapeutic-Proteins-Using-Nuclease-Technology-1568482http://www.finanzen.net/nachricht/Cellectis-Launches-a-Partnership-with-Total-for-Exploratory-Research-into-Microalgae-Based-Substitutes-for-Oil-Products-1554673 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: <b>Cellectis (Paris:ALCLS), the French genome engineering specialist, is ...http://www.finanzen.net/nachricht/Cellectis-Launches-a-Partnership-with-Total-for-Exploratory-Research-into-Microalgae-Based-Substitutes-for-Oil-Products-1554673http://www.finanzen.net/nachricht/Cellectis-plant-sciences-and-Bayer-CropScience-strengthen-genome-engineering-partnership-1544063 <style type="text/css"> <!-- .bwalignc {text-align: center} .bwuline {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Regulatory News: Cellectis plant sciences, the plant genome engineering company and ...http://www.finanzen.net/nachricht/Cellectis-plant-sciences-and-Bayer-CropScience-strengthen-genome-engineering-partnership-1544063http://www.finanzen.net/nachricht/Cellectis-bioresearch-and-Syngene-Announce-Partnership-on-the-Development-of-Customized-Cell-Lines-1511822 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Regulatory News: <!-- sh_cad_1 --> Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Paris:ALCLS), ...http://www.finanzen.net/nachricht/Cellectis-bioresearch-and-Syngene-Announce-Partnership-on-the-Development-of-Customized-Cell-Lines-1511822http://www.finanzen.net/nachricht/Starbucks-Enters-Five-New-Cities-Across-Mainland-China-1511823 <style type="text/css"> <!-- .bwalignc {text-align: center} --> </style> Riding on the momentum from the opening of its 500^th store in Mainland China in October, Starbucks Coffee Company (NASDAQ: SBUX) entered ...http://www.finanzen.net/nachricht/Starbucks-Enters-Five-New-Cities-Across-Mainland-China-1511823